Hydrocortisone, neomycin
Sold as Neo-cortef, Hycortin plus, Adco-neoderm, Neo enticort h topical, Neo-enticort h eye/ear
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Background
Registration
- Applicants
- 4
- Registrations
- 7
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Upjohn South Africa (Pty) Ltd | Neo-cortef | 1 %, 1,5 % | G1924, H1108 | Not determined | None |
| The Premier Pharmaceutical Co LtdCancelled | Hycortin plus, Neo enticort h topical | ointment | G1937, G2284 | Not determined | None |
| Adcock ingram limitedCancelled | Adco-neoderm | Not stated | G2023 | Not determined | None |
| Propan Pharmaceuticals (Pty) Ltd *Cancelled | Neo-enticort h eye/ear | ointment, suspension | H1304, H1305 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Neo-cortef 1 % 1 G HYDROCORTISONE ACETATE A 10 MG NEOMYCIN SULPHATE A 5,5 MG | 1 % | G1924 | Old Medicine | Not determined | None |
| Hycortin plus 1 G HYDROCORTISONE ACETATE A 0,01 G NEOMYCIN SULPHATE A 0,035 G | Not listed | G1937 | Cancelled | Not determined | None |
| Adco-neoderm EACH 100 g CONTAINS HYDROCORTISONE ACETATE A 1,0 g NEOMYCIN SULPHATE A 0,5 g | Not listed | G2023 | Cancelled | Not determined | None |
| Neo enticort h topical ointment 10 G HYDROCORTISONE ACETATE A 0,1 G NEOMYCIN A 0,0385 G | Ointment | G2284 | Cancelled | Not determined | None |
| Neo-cortef 1,5 % EACH GRAM CONTAINS HYDROCORTISONE ACETATE A 15,0 mg NEOMYCIN A 3,5 mg | 1,5 % | H1108 | Old Medicine | Not determined | None |
| Neo-enticort h eye/ear ointment EACH GRAM CONTAINS HYDROCORTISONE ACETATE A 15 mg NEOMYCIN A 3,5 mg | Ointment | H1304 | Cancelled | Not determined | None |
| Neo-enticort h eye/ear suspension EACH 1 ml CONTAINS HYDROCORTISONE ACETATE A 15 mg NEOMYCIN A 3,5 mg | Suspension | H1305 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Hydrocortisone
- maximum concentration of 1 percent in preparations intended for application to the skin, and
- in a maximum concentration of 1 percent used in combination with miconazole for topical application in the treatment of athlete’s foot. (S2)
Consolidated Schedules 06 July 2026, lines 6648 to 6652
S4: Neomycin
- except when registered in terms of the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act 36 of 1947).
Consolidated Schedules 06 July 2026, lines 7224 to 7225
S2: Hydrocortisone
- maximum concentration of 1 percent in preparations intended for application to the skin, and
- in a maximum concentration of 1 percent used in combination with miconazole for topical application in the treatment of athlete’s foot. (S4)
Consolidated Schedules 06 July 2026, lines 2110 to 2114
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.